N/A
N=36
Development and Evaluation CAT and Youth
CAT Intervention Group · Control Group
Bottom Line
View on ClinicalTrials.gov: NCT05950672 ↗Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Number of Participants Whose Cats Changed From Insecure to Secure Attachment Classification From T1 to T3 — 6; 1 Participants — p=.0156
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CAT Intervention Group (Behavioral)
- Age
- Pediatric · 8+ yrs
- Sex
- All
- Sponsor
- Oregon State University
- Primary completion
- Jun 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Whose Cats Changed From Insecure to Secure Attachment Classification From T1 to T3 |
6; 1 | .0156 sig |
| SECONDARY Number of Participants Who Participated in Walking Their Cat at T2 |
18; 11 | .0255 sig |
Summary
This R21 provides a multidisciplinary One Health approach to developing and evaluating a novel Cat Assisted Training (CAT) animal assisted intervention (AAI) for early adolescents with developmental disabilities (DD) and their family cat. Cat social behavior and welfare is heavily influenced by human behavior and training, making it highly likely that cats would also benefit from this program. There remains a critical need for further empirical evaluation of AAI practices, especially those that target the specific needs of youth with disabilities. Further extending the development and evaluation of activity-based AAIs beyond those that include dogs and horses also helps address the critical need to consider and include diverse human participants, creating new equitable opportunities for AAI involvement to those who may have access to cats, but not dogs and horses (due to practical, health, cultural, socio-economic, or other personal reasons).
Eligibility Criteria
Inclusion Criteria
- Child with a developmental disability per parental report.
- Family owns a family cat.
Exclusion Criteria
- Can not follow instructions.
Data sourced from ClinicalTrials.gov (NCT05950672). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.